Editing genes to fix genetic mutations could revolutionize how we treat disease, but gene editing research is only in early stages, and plenty still needs to learned before we know it's safe for widespread use.  In this episode of Limelight Alpha's Talking Stocks, 7Investing Lead Advisor, Maxx Chatsko, joins Todd Campbell to explains the pros and cons of gene editing. The duo discuss: How gene editing, including CRISPR Cas, compares to RNAi therapies;  What gene editing companies are furthest along in their research;  What data is on tap from leading gene editing stocks, includ ..read more

The latest episode of Limelight Alpha’s Talking Stocks is packed with insight. -What’s causing Pinterest’s shares to crash? -Is Amazon in trouble? -A 5G stock you can buy now -Is Robinhood a buy? -Is it safe to invest in China stocks? -A slate of new stocks worth watching, and -Todd’s latest stock buys. A free trial to our stock idea research: https://seekingalpha.com/author/limelight-alpha-management-partners/research If you enjoy our content, please subscribe on YouTube: https://www.youtube.com/c/TalkingStocksbyLimelightAlpha Follow us on Twitter: https://twitter.com/AlphaLimelight  ..read more

We're off this week, but we didn't want to leave you high and dry without any show at all! Enjoy a clip from our 2/10 episode (https://anchor.fm/limelight-alpha/episodes/Talking-Stocks---Bitcoin--Weed-Stocks--and-Buying-Strategy-eq7kfj) where Joe talks about his hesitancy (not anymore!) to buy stocks at all-time highs, and the valuable lesson he learned from buying cannabis ETF MJ near its peak. Our scoring model tends to reward stocks that are trading well above their moving averages - often at 52-week or all-time highs. This short is packed with tons of great buying and holding advice f ..read more

We're always working hard at Limelight Alpha to give you some great content and ideas - this week's episode is no exception! Here's our agenda: - A silver lining of 6% inflation - 6% higher Social Security payouts! Todd explains how some of our older (but young at heart) listeners may benefit next year. - Our investing style(s) - We have a discussion about where on the investing "spectrum" we fall: daytrader, swing/cyclical trader, or long-term holder. - Then we dive into some of our trades over the past week. Todd was busy buying and selling! - Finally, a back-and-forth of 8 high-scoring sto ..read more

A 4 day week doesn't mean there's any less to talk about! We've got another jam-packed show for you - below is our agenda: - Amazon (AMZN)'s new CEO: A potential catalyst for a breakout long in the making? - Generac (GNRC): an interesting seasonal play as we come into the height of hurricane season - Didi (DIDI): A great example of why we avoid Chinese ADRs - Todd and Joe's recent trades: We were busy adding and expanding positions this week, including DLTH, APPS, CRWD, and more - Finally, 10 (+1 bonus!) high-scoring stocks to add to your watchlist If you haven't already, consider signing up ..read more

In this short from our 7/2/21 episode, we go deep into Robinhood's recent S-1 filing to extract all the info you need to invest (or not) in the future stock. There's no set IPO date yet (as of 7/7/21), but stay tuned: things happen fast. There were some surprising numbers in the S-1, including a billion-dollar loss in Q1 of this year. We'll tell you why that's not as alarming as it sounds. Follow us on Twitter! https://twitter.com/AlphaLimelight If you're subscribed to us on YouTube, thanks so much! If not, please check us out: https://www.youtube.com/c/TalkingStocksbyLimelightAlpha You can a ..read more

I know I say it every week, but this week it's really true - this episode is DENSE and packed with great content! Here's what you can expect: - Virgin Galactic (SPCE) follow-up: what happened over the past week & where we go from here - Krispy Kreme (DNUT) and LegalZoom (LZ) follow-up: who won the battle of the IPOs? - Robinhood IPO: another huge offering in the works! We read through the S-1 form. - Novocure (NVCR) & Intellia (NTLA): both in the news this week, hear some vintage-style Todd Campbell commentary on these 2 healthcare stocks. - Tech seasonality: A follow-up to last week ..read more

We've got another jam-packed episode for you this week! Here's our agenda: - Virgin Galactic (SPCE) is having one heck of a day (Friday, 6/25)! Todd fills us in on the reasoning behind this and the chart setup. Also, why he's not selling this vertical! - Tech is climbing rapidly in our sector ranking. We take some time to unravel why this is, and what you can expect from a historically excellent month for the NASDAQ. - 2 live read-throughs! We take a look at the S-1 filings of 2 upcoming IPOs: Krispy Kreme and LegalZoom. Then we discuss which we're more likely to invest in. - Finally, a tech-h ..read more

Time for an old-fashioned Talking Stocks episode! It's all individual stocks this week - after all, talking stocks is what we do. Here's what you can expect from a jam-packed episode: - Big news from Biogen (BIIB)! Todd fills us in on a controversial Alzheimer's drug approval.  - World Wrestling Entertainment (WWE) had a huge breakout this week! This is a classic "covid reopening play" we've talked about on the show for so long.  - Celsius Holdings (CELH) had some ups and downs this week. We explain why we still like the stock. - We also revisit Tenneco (TEN), which has seen some im ..read more

Nvidia (NVDA) put up some massive growth numbers in their 1st quarter 2021 earnings report (their fiscal year 2022). They reported impressive growth in both their gaming division and their data centers. We didn't read the press release beforehand, so these are our first reactions! It's impressive Nvidia was able to grow this much in spite of a global chip shortage. Let us know what you think!   Follow Todd on Twitter: https://twitter.com/ebcapital Subscribe to our stock picking service: https://seekingalpha.com/checkout?service_id=mp_46  Check out some of our other earnings deep dive ..read more